Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden. | Cell Rep Med | 2021 | 34873589 | PubTator, text mining | PubMed |
| Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma. | Biosci Rep | 2021 | 34870709 | PubTator, text mining | PubMed |
| A Pulmonary Vascular Model From Endothelialized Whole Organ Scaffolds. | Front Bioeng Biotechnol | 2021 | 34869270 | PubTator, text mining | PubMed |
| COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas. | Front Oncol | 2021 | 34868960 | PubTator, text mining | PubMed |
| Novel emerging biomarkers to immunotherapy in kidney cancer. | Ther Adv Med Oncol | 2021 | 34868351 | PubTator, text mining | PubMed |
| Co-Exposure of Cardiomyocytes to IFN-γ and TNF-α Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopathy. | Front Immunol | 2021 | 34867992 | PubTator, text mining | PubMed |
| Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients. | Front Immunol | 2021 | 34867983 | PubTator, text mining | PubMed |
| An Integrated Analysis Reveals Geniposide Extracted From Gardenia jasminoides J.Ellis Regulates Calcium Signaling Pathway Essential for Influenza A Virus Replication. | Front Pharmacol | 2021 | 34867371 | PubTator, text mining | PubMed |
| Capsule-dependent impact of MAPK signalling on host cell invasion and immune response during infection of the choroid plexus epithelium by Neisseria meningitidis. | Fluids Barriers CNS | 2021 | 34863201 | PubTator, text mining | PubMed |
| Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment. | Dis Markers | 2021 | 34840630 | PubTator, text mining | PubMed |
| Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity. | Semin Immunol | 2021 | 34836774 | PubTator, text mining | PubMed |
| The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review. | Vaccines (Basel) | 2021 | 34835155 | PubTator, text mining | PubMed |
| Leucosceptoside A from Devil's Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes. | Molecules | 2021 | 34834106 | PubTator, text mining | PubMed |
| The Role of Chemokines in Cervical Cancers. | Medicina (Kaunas) | 2021 | 34833360 | PubTator, text mining | PubMed |
| Secretome Analysis of Rabbit and Human Mesenchymal Stem and Endothelial Progenitor Cells: A Comparative Study. | Int J Mol Sci | 2021 | 34830165 | PubTator, text mining | PubMed |
| Immune Tolerance in the Oral Mucosa. | Int J Mol Sci | 2021 | 34830032 | PubTator, text mining | PubMed |
| Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. | Sci Immunol | 2021 | 34826259 | PubTator, text mining | PubMed |
| High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. | Nat Commun | 2021 | 34824220 | PubTator, text mining | PubMed |
| Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. | Math Biosci Eng | 2021 | 34814296 | PubTator, text mining | PubMed |
| Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study. | Ann Transl Med | 2021 | 34805359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=71